Login / Signup

Inpatient COVID-19 mortality has reduced over time: Results from an observational cohort.

Katie BechmanMark YatesKirsty MannDeepak NagraLaura-Jane SmithAndy I RutherfordAmit PatelJimstan PeriselnerisDavid WalderRichard J B DobsonZeljko KraljevicJames H T TeoWilliam BernalRichard BarkerJames B GallowaySam Norton
Published in: PloS one (2022)
There has been substantial improvements in COVID-19 mortality in the second wave, even accounting for demographics, comorbidity, and disease severity. Neither dexamethasone nor remdesivir appeared to be key explanatory factors, although there may be unmeasured confounding present.
Keyphrases
  • coronavirus disease
  • sars cov
  • cardiovascular events
  • risk factors
  • palliative care
  • mental health
  • respiratory syndrome coronavirus
  • low dose
  • cardiovascular disease
  • cross sectional